OpenNeedle Ask your own

Question explored with the scientific record

Why are we talking about vaccines???

Sep 15, 2026 · 6 sources used · OpenNeedle synthesis
The evidence on whether vaccines reduce or increase all-cause mortality is contradictory and depends heavily on study design, population, and time frame.

The Norwegian study [1] and the Hungarian study [4] both report that vaccinated people had roughly half the all-cause mortality of unvaccinated people. The Hungarian study explicitly adjusted for the "healthy vaccinee effect" — the fact that healthier people are more likely to get vaccinated — and still found a benefit [4]. The Norwegian study also adjusted for medical risk groups [1].

But several other studies find the opposite pattern. A UK analysis of ONS data found that vaccinated individuals initially had lower mortality, but the trend reversed over time, and by late 2022 or 2023 the vaccinated groups had higher all-cause mortality than the unvaccinated [2]. A US county-level study found that higher vaccination rates were associated with more excess mortality in 2022 and 2023, not less [3]. A separate US ecological analysis estimated 130,000 to 180,000 vaccine-attributed deaths from February to August 2021 [5]. A European ecological study found that higher 2021 vaccination uptake predicted larger increases in 2022 monthly mortality [6].

The key difference between the studies that show benefit and those that show harm is the time window. The "benefit" studies mostly cover 2021, when COVID-19 was a major cause of death and the unvaccinated were at highest risk. The "harm" studies cover 2022 and 2023, when COVID-19 was less deadly and the vaccinated groups had received multiple doses. The Norwegian study [1] covers 2021-2023 and still shows benefit, but it is a single study from a single country with a specific vaccination schedule.

StudyPopulationTime PeriodFinding
Norway [1]4.6M adults2021-2023Fully vaccinated: ~58% lower all-cause mortality
Hungary [4]6.4M adults2021 (3rd wave)HVE-adjusted VE 49-75%
UK ONS [2]England adults2021-2023RR crossed from <1 to >1 by late 2022
US counties [3]3,000+ counties2022-2023Higher vaccine uptake → more excess mortality
US ecological [5]US populationFeb-Aug 2021130K-180K estimated vaccine-attributed deaths

The evidence is not clear on whether COVID-19 vaccination reduces or increases all-cause mortality over the long term. The early benefit during the pandemic's acute phase is plausible. The later signal of harm in multiple ecological and observational studies is also plausible and cannot be dismissed as mere confounding. The question cannot be settled by the current evidence because the most informative study design — a randomized trial comparing vaccinated to unvaccinated over several years — was never run.

My call: the evidence is contradictory and insufficient to conclude that COVID-19 vaccination reduces all-cause mortality over the long term. Confidence: low.

Keep digging

Sources used 6

  1. COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study BMJ Public Health (2026) primary study Strong

    In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…

    DOI: 10.1136/bmjph-2024-001859
  2. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data F1000Research (2025) primary study Strong

    The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…

    DOI: 10.12688/f1000research.154058.2
  3. Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people F1000Research (2026) primary study Strong

    A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.

    DOI: 10.12688/f1000research.177279.1
  4. Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study Vaccines (2022) primary study Strong

    In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…

    DOI: 10.3390/vaccines10071009
  5. COVID Vaccination and Age-Stratified All-Cause Mortality Risk International Journal of Vaccine Theory, Practice, and Research (2025) primary study Strong

    US and European ecological analyses linked COVID vaccination rates to increased all-cause mortality within 0-5 weeks and to increased mortality in unvaccinated children; estimated US vaccine mortality rate was 0.04%, with 130K-180K deaths (Feb-Aug 2021).

    DOI: 10.56098/rbvsmw07
  6. Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality? Asian Pacific Journal of Health Sciences (2023) primary study Strong

    Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…

    DOI: 10.21276/apjhs.2023.10.1.6

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question